You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cyclosporine

Showing 26 - 50 of 1,620
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dermatitis, Atopic, Eczema Trial in Worldwide (Lebrikizumab, Lebrikizumab-matching Placebo)

Recruiting
  • Dermatitis, Atopic
  • Eczema
  • Lebrikizumab
  • Lebrikizumab-matching Placebo
  • Nantes, Loira Atlantico, France
  • +1 more
Jun 8, 2022

Cholesterol Trial (ezetimibe, Comparator: cyclosporine)

Completed
  • Cholesterol
  • (no location specified)
Feb 7, 2022

Dry Eye Trial in Guangzhou (Cyclosporine, oculus keratograph, in vivo laser confocal microscopy, Functional slit lamp

Recruiting
  • Dry Eye
  • Cyclosporine
  • oculus keratograph, in vivo laser confocal microscopy, Functional slit lamp biomicroscopy
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Feb 9, 2022

Ocular Surface Disease Trial in Needham (Restasis)

Recruiting
  • Ocular Surface Disease
  • Needham, Massachusetts
    BostonSight
Mar 6, 2022

COVID-19 Trial in Philadelphia (Cyclosporine)

Completed
  • COVID-19
  • Cyclosporine
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 7, 2022

Severe Aplastic Anemia Trial run by the NHLBI (Cohort 1: hATG, CsA, EPAG Day 14 to Month 6, Cohort 2: hATG, CsA, EPAG Day 14 to

Recruiting
Has Results
  • Severe Aplastic Anemia
  • Cohort 1: hATG, CsA, EPAG Day 14 to Month 6
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 5, 2022

Immune Tolerance, Immunosuppression, Liver Transplant; Complications Trial in Tianjin (Tacrolimus or Cyclosporine A)

Not yet recruiting
  • Immune Tolerance
  • +2 more
  • Tacrolimus or Cyclosporine A
  • Tianjin, Tianjin, China
    Tianjin First Central Hospital
Nov 23, 2023

Ocular Surface Disease, Ocular Inflammation Trial in Rome (CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion, cationorm eye

Active, not recruiting
  • Ocular Surface Disease
  • Ocular Inflammation
  • CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion
  • cationorm eye drops
  • Rome, Italy
    University Campus Bio Medico
Jan 5, 2022

GVHD in Eye Trial in Beijing (Cyclosporine, tacrolimus)

Completed
  • Graft Versus Host Disease in Eye
  • Beijing, Beijing, China
    Peking University Third Hospital
Mar 14, 2022

Takotsubo Cardiomyopathy Trial in Germany (Cyclosporine A, Placebo)

Not yet recruiting
  • Takotsubo Cardiomyopathy
  • Cyclosporine A
  • Placebo
  • Bad Nauheim, Germany
  • +30 more
Jul 7, 2023

Dry Eye Disease Trial in United States (CequaTM (Cyclosporine 0.09%) ophthalmic solution)

Completed
  • Dry Eye Disease
  • CequaTM (Cyclosporine 0.09%) ophthalmic solution
  • Fort Myers, Florida
  • +4 more
Sep 8, 2022

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Brentuximab Vedotin, Cyclosporine, Pharmacokinetic

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Hemophagocytic Syndrome Trial in Chongqing (cyclophosphamide, VP-16, Dexamethasone)

Recruiting
  • Hemophagocytic Syndrome
  • Chongqing, China
    The Second affiliated Hosptial of Chongqing medical University
Jun 28, 2023

SARS (Disease) Trial in Houston (Cyclosporine, Standard of Care Treatment)

Recruiting
  • SARS (Disease)
  • Cyclosporine
  • Standard of Care Treatment
  • Houston, Texas
    Baylor College of Medicine
Oct 26, 2021

Severe Aplastic Anemia Trial in Worldwide (eltrombopag, Cyclosporine)

Completed
  • Severe Aplastic Anemia
  • Ribeirao Preto, SP, Brazil
  • +19 more
Jun 29, 2022

Conjunctivitis, Vernal Trial in Paris (Cyclosporine NOVA22007 0.05%, Cyclosporine NOVA22007 0.1%, Vehicle)

Completed
Has Results
  • Conjunctivitis, Vernal
  • Cyclosporine NOVA22007 0.05%
  • +2 more
  • Paris, France
    Groupe Hospitalier Bichat-Claude Bernard
Nov 12, 2021

Eltrombopag Trial in Assiut (Eltrombopag)

Completed
  • Eltrombopag
  • Assiut, Egypt
    Facility of medicine
Jan 13, 2022

Kidney Transplant Trial in Korea, Republic of (Advagraf, Corticosteroid)

Completed
  • Kidney Transplant
  • Busan, Korea, Republic of
  • +8 more
Jul 26, 2022

Healthy Volunteer Study Trial in Montreal (AT-527 550 mg + cyclosporine)

Completed
  • Healthy Volunteer Study
  • AT-527 550 mg + cyclosporine
  • Montreal, Quebec, Canada
    Atea Study Site
Jul 27, 2021

Primary Autoimmune Hemolytic Anemia Trial in Assiut,, Assiut (Cyclosporine, Rituximab)

Recruiting
  • Primary Autoimmune Hemolytic Anemia
  • Assiut,, Assiut, Egypt
  • +1 more
Oct 20, 2021

Pharmacological Action Trial (Rituximab, Dexamethasone)

Not yet recruiting
  • Pharmacological Action
  • (no location specified)
Sep 22, 2022

Aplastic Anemia Trial in Tianjin (Avatrombopag 20 MG Oral Tablet)

Recruiting
  • Aplastic Anemia
  • Avatrombopag 20 MG Oral Tablet
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Oct 4, 2022

Healthy Trial in Tempe (Danicopan, Cyclosporine, Tacrolimus)

Completed
  • Healthy
  • Tempe, Arizona
    Clinical Trial Site
Nov 3, 2021

Aplastic Anemia Trial in Beijing (Avatrombopag+CsA)

Not yet recruiting
  • Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Moderate-to-severe Atopic Dermatitis Trial (Nemolizumab, CD14152 )

Withdrawn
  • Moderate-to-severe Atopic Dermatitis
  • (no location specified)
Jan 6, 2022